Peptides, explained

Start here

Peptide 101What happens at a peptide telehealth consultationCompoundingWhat telehealth peptide prescribing actually looks likeRegulatory10 questions to ask before buying any peptide onlinePeptide 101Are peptides safe? What the answer actually depends onLabsThe baseline blood panel: what to test before any peptide protocol

All peptides guides (113)

• Agonist vs antagonist: how a peptide turns a receptor on or off

  An agonist switches a receptor on; an antagonist blocks it. Here is the plain-English difference, with a key-and-lock analogy and why it matters for peptides.

• Are peptides safe? What the answer actually depends on

  Are peptides safe? The honest answer depends on the compound, the source, the dose, and the person. Here's the clinical path vs unregulated buying.

• Are peptides steroids? Clearing up the biggest misconception

  Peptides and steroids are completely different — different structures, mechanisms, and legal status. Here's why people confuse them and what sets them apart.

• Beta turns: the hairpin bends in a peptide chain

  A beta turn is a tight bend that lets a peptide chain reverse direction in just a few residues. Here's what beta turns are and why they matter for shape.

• BPC-157 research: what the literature actually says

  An honest summary of the BPC-157 research landscape: where the evidence is strong, where it is limited, and what the open questions are. Useful primer for physicians, patients, and anyone parsing the online discourse.

• BPC-157 research: what the published literature shows

  BPC-157 has been studied for over thirty years, mostly in animals. Here is the BPC-157 research base today: what is well-described, what is still open, and where humans fit in.

• BPC-157 side effects and safety profile

  What is known and not known about the BPC-157 safety profile. Animal tolerance data is generally favorable, but robust human safety trials are not available. Here is a balanced summary.

• BPC-157: what this body protection compound actually is

  BPC-157 is a synthetic 15-amino-acid peptide derived from a protein found in gastric juice. Here is what it is in plain English, and why it has attracted so much research interest.

• C-terminal amidation: the finishing touch on many peptides

  C-terminal amidation is a final tweak to a peptide's tail end. Here is how it changes the molecule and why about half of active peptides have it.

• Caffeine and L-theanine: the well-studied focus stack

  Caffeine and L-theanine: a plain-English look at why this pairing is one of the best-studied focus stacks, what the research shows, and the trade-offs.

• Cognitive testing: how researchers measure "sharper"

  How do researchers measure claims that something made you feel "sharper"? Here is how cognitive testing works, and why the details matter most.

• Cyclic vs linear peptides: why shape changes how they work

  Cyclic and linear peptides have the same building blocks but different shapes. Here is how a loop versus a strand changes how a peptide works in the body.

• Cycling peptides: what the research suggests about breaks

  Why do peptide protocols include breaks? Receptor desensitization and tachyphylaxis are real biological phenomena. Here's what the research says about cycling.

• Disulfide bonds: how peptides hold their shape

  Disulfide bonds are chemical bridges between cysteine residues that lock a peptide into its working shape. Here's how they form and why they matter.

• Endogenous vs exogenous peptides: natural vs synthetic

  Endogenous vs exogenous peptides explained in plain English: your body makes some, a lab makes others, and many therapies copy the natural version on purpose.

• Frozen Shoulder, Plantar Fasciitis, and Tennis Elbow: Midlife's Common Three

  Why do frozen shoulder, plantar fasciitis, and tennis elbow cluster in your 40s and 50s? A look at the shared cause behind midlife soft tissue pain.

• Glycine: the smallest amino acid, explained

  Glycine is the smallest amino acid and a key building block of collagen. Here's what glycine does, why it matters, and whether it's essential.

• How angiogenesis works, and why it matters for healing

  Angiogenesis is how your body grows new blood vessels to heal tissue. Here is what it is, how it works, and why peptide researchers study it, in plain English.

• How BPC-157 works: the mechanism behind the research

  BPC-157's proposed mechanisms span angiogenesis, nitric oxide signaling, growth factor upregulation, and gut mucosal protection. Here is what the preclinical literature actually shows.

• How KPV interacts with melanocortin receptors

  KPV is the three-amino-acid tail of alpha-MSH. Animal research links it to anti-inflammatory pathways. Here is what the KPV mechanism actually looks like, in plain English.

• How peptide dosing differs from conventional drug dosing

  Peptide dosing is measured in micrograms, not milligrams, and timed to body rhythms. Here is why the units, timing, and route differ from a typical pill.

• How peptides act on receptors: the key and lock explained

  How peptides interact with cell-surface receptors in plain English — the key-and-lock model, conformational change, the cascade that follows, and why specificity matters.

• How peptides are different from hormones

  Peptides vs hormones in plain English: most hormones are peptides, but the labels describe different things. Here is the clean way to tell them apart.

• How peptides are different from supplements

  Peptides vs supplements in plain English: peptides are prescribed compounds prepared by a pharmacy. Supplements are not. Here is the clean way to tell them apart.

• How peptides are made: from amino acid to injectable

  How peptides are made in plain English: amino acids are linked one at a time on a solid bead, purified, tested, and shipped to a compounding pharmacy.

• How TB-500 works: actin regulation and tissue signaling

  TB-500's proposed mechanisms center on actin sequestration, cell migration, anti-inflammatory signaling, and angiogenesis. Here is what the preclinical research actually shows.

• How to evaluate any peptide: a framework from evidence-based medicine

  How to evaluate any peptide: a plain-English framework from evidence-based medicine. Five questions that separate hype from useful research. Educational only.

• How to have a goals-first conversation with your physician

  Before naming a compound, start with what you actually want. Here's how to structure a productive goals-first conversation with a physician about peptide options.

• How to talk to your healthcare provider about peptide therapy

  How to bring up peptide therapy with your healthcare provider without it feeling awkward. Bring goals, recent labs, and questions — and what to expect back.

• Humanin: the mitochondrial peptide longevity researchers study

  Humanin is a peptide encoded in mitochondrial DNA, studied for its role in cell survival and aging. Here's what it is, how it works, and what research shows.

• Inflammation: when it heals and when it harms

  Acute inflammation heals injuries; chronic inflammation quietly harms. Here is the difference between the two and why one is protective and the other is not.

• Intranasal peptide delivery: what it is and which peptides use it

  Intranasal sprays let small peptides reach the bloodstream and brain without injection. Here is which peptides use this route and the trade-offs.

• Isoelectric point: why some peptides are hard to dissolve

  A peptide dissolves worst at its isoelectric point, the pH where its net charge is zero. Here is what that means for mixing and storing peptides.

• KPV and the published anti-inflammatory research

  KPV is a tripeptide fragment of alpha-MSH studied in animal models of IBD and colitis. FDA removed it from Category 2 on April 22, 2026, and it is not on the 503A bulks list.

• KPV: the alpha-MSH fragment and what it is

  KPV is a three-amino-acid fragment of alpha-MSH that has been studied for anti-inflammatory effects, mostly in animal models. Here is what it is, in plain English.

• Larazotide: the peptide studied for leaky gut, explained

  Larazotide is an investigational peptide studied for its role in regulating gut tight junctions. Here's what it is, how it works, and where research stands.

• Leaky gut: the term, the science, and the overreach

  Leaky gut is a real biology term for intestinal permeability, but the wellness version overreaches. Here is what the science supports and what it does not.

• Local vs systemic peptide action in injury recovery

  Some peptides act mainly where injected; others travel body-wide. Here is what local vs systemic action means for injury recovery, in plain English.

• N-terminal acetylation: a common peptide tag

  N-terminal acetylation is a common chemical tag added to the front of a protein. Here's what it is, what it does, and why it matters for peptides.

• Native, synthetic, compounded: three words people confuse

  Native vs synthetic vs compounded peptide: a plain-English guide to three words people mix up, what each actually means, and why the distinction matters.

• Off-label prescribing explained: what it means and why it is common

  What off-label prescribing is in plain English: it is legal, it is common, and most physicians do it every week. Why peptide protocols often live in this space.

• PEGylation: attaching PEG to make peptides last longer

  PEGylation attaches polyethylene glycol chains to a peptide to slow how fast the body clears it. Here's what PEGylation is and why drug makers use it.

• Pentadeca arginate (PDA) vs BPC-157: what the research shows

  Pentadeca arginate (PDA) and BPC-157 are closely related peptides. Here is how they compare, and what the published research does and does not show for each.

• Peptide 101: the most-asked beginner questions answered

  Peptide therapy FAQ for beginners. Plain-English answers on how peptides work, who prescribes them, and what to expect. Educational only.

• Peptide aggregation: why peptides clump together

  Peptide aggregation is when peptide molecules clump together instead of staying separate. Here's what it is, why it happens, and why it matters.

• Peptide bonds: the chemical link that holds peptides together

  A peptide bond is the chemical clasp that joins amino acids into a chain. Here is what it is, how it forms, and why it decides how peptides behave.

• Peptide denaturation: what makes a peptide lose its shape

  Peptide denaturation means losing the 3D shape a peptide needs to work. Learn what causes it, whether it's reversible, and why storage matters.

• Peptide depot formulations explained simply

  A peptide depot formulation traps the drug in tiny beads so it releases over weeks or months. Here is what a depot injection is and how it works.

• Peptide glycosylation: sugars attached to peptides

  Peptide glycosylation is the attachment of sugar chains to a peptide. Here's what N-linked and O-linked mean, why it matters, and how it changes function.

• Peptide half-life basics: why dosing schedules vary

  Why do some peptides require daily injections while others work weekly? The answer is half-life. Here's a plain-English explanation of peptide pharmacokinetics.

• Peptide half-life: how long peptides last in the body

  Peptide half-life is how long a peptide lasts in the body before half is cleared. Here is why most peptides act fast, clear fast, and why that shapes dosing.

• Peptide half-life: why some need daily shots and others don't

  Half-life is how fast your body clears a peptide. It explains why some peptides need daily shots and others last for days. Here is the plain-English version.

• Peptide hydration shell: the water layer around peptides

  A peptide hydration shell is the ordered layer of water that surrounds a peptide. Here's how it forms and why it shapes a peptide's folding and function.

• Peptide molecular weight: what daltons mean

  Peptide molecular weight is the total mass of a peptide, measured in daltons. Here's what a dalton is, why kDa is used, and how to estimate mass.

• Peptide names decoded: reading CJC-1295, GHRP-6, and more

  Peptide names like CJC-1295 and GHRP-6 follow a pattern. Here is how to read the acronyms, discovery codes, and analog suffixes in any peptide name.

• Peptide net charge: why peptides carry a charge

  A peptide's net charge is the sum of its positive and negative charges at a given pH. Here's what gives a peptide its charge and why it matters.

• Peptide PhDs: how academic research is catching up to the clinic

  Clinical peptide use has outrun the published evidence in many cases. Here's how academic research is catching up, and why the gap matters, in plain English.

• Peptide phosphorylation explained in plain English

  Peptide phosphorylation is the body adding a phosphate tag to switch a protein on or off. Here is what it is, how it works, and why it matters.

• Peptide purity and the certificate of analysis: how to read a COA

  A certificate of analysis tells you what is actually in a peptide vial. Here is how to read one, what to look for, and where COAs fall short.

• Peptide receptor selectivity: why some peptides are more targeted

  Why do some peptides act like a precise key and others hit many locks? Receptor selectivity explains targeting and side effects, in plain English.

• Peptide risks and contraindications: what everyone should know

  Peptide therapy risks and contraindications, in plain English. Who should not use peptides, common side effects, and the safety floor. Educational only.

• Peptide secondary structure: the helix and the sheet

  Peptide secondary structure is the local folding of the chain into alpha helices and beta sheets. Here is how hydrogen bonds give a peptide its shape.

• Peptide stacking 101: principles for safe combinations

  Peptide stacking means combining peptides that work on different pathways. Here are the principles physicians use and the mistakes to avoid.

• Peptide synergism: how physicians think about combination protocols

  Peptide combinations explained: how physicians think about pairing peptides, where the evidence is strongest, and why more is not always better. Educational.

• Peptide tertiary and quaternary structure, explained

  Tertiary structure is a protein's full 3D fold. Quaternary structure is two or more folded chains assembled together. Here's what that means.

• Peptide therapy research: how the field has evolved since 1921

  Peptide medicine began in 1921 with insulin. A century later, 100+ peptide drugs are on the market. Here's the short history of how the field got here.

• Peptide-drug conjugates: targeted delivery, explained

  A peptide-drug conjugate uses a targeting peptide to deliver a drug directly to diseased cells. Here's how PDCs work and what FDA-approved examples look like.

• Peptides 101: 10 questions first-time patients ask

  Ten plain-English answers to the most common questions first-time patients ask about peptide therapy — what they are, how they work, and what to ask a physician.

• Peptides and cancer history: why the IGF-1 question matters

  Some peptides raise IGF-1, a growth signal. Here is why a personal or family cancer history changes the peptide conversation, explained in plain English.

• Peptides and the blood-brain barrier explained

  The blood-brain barrier blocks most peptides from reaching the brain. Here is what the barrier is, why it stops peptides, and how a few get through.

• Peptides vs hormones: the overlap and the distinction

  Every peptide is not a hormone, and every hormone is not a peptide. Here's a plain-English map of where the two overlap and where they diverge.

• Peptides vs small-molecule drugs: keys vs hammers

  Peptides bind to specific receptors like a key in a lock. Small-molecule drugs work differently. Here's what that distinction means for how each interacts with your body.

• Probiotics, Prebiotics, and Postbiotics: What Actually Separates Them

  What is the difference between probiotics and prebiotics? A plain-English guide to all three gut-health terms, backed by the real scientific definitions.

• Proline and cis-trans isomerization in peptides

  Proline cis-trans isomerization is a slow flip in the peptide bond before proline. Here's what it is, why proline is unusual, and how enzymes speed it up.

• PRP, prolotherapy, and where peptides sit in regenerative care

  Regenerative care spans PRP, prolotherapy, and peptides — three different materials with different FDA rules and very different levels of human evidence.

• Racemization and D-amino acids: why peptide chirality matters

  D-amino acids are mirror-image building blocks that help peptides resist breakdown. Here is how chirality works and why drug designers use them.

• Receptor specificity: why peptides are more targeted than small-molecule drugs

  Peptides are more receptor-specific than most small-molecule drugs. Here is what that means in plain English — and why specificity is not risk-free.

• Salt bridges: the electrostatic links that shape peptides

  A salt bridge forms when a positive side chain like lysine pairs with a negative one like glutamate. See the forces at work and why its effect is modest.

• Semax: the nootropic peptide, explained

  Semax is a synthetic peptide from an ACTH fragment, studied in Russia for focus. Here's what it is, how it works, and its US regulatory status.

• Short-chain fatty acids: how gut bacteria talk to immunity

  Short-chain fatty acids are the messengers gut bacteria make from fiber. Here is how butyrate and its cousins help calm and coordinate the immune system.

• Soft-tissue healing timelines: what biology allows

  Soft-tissue healing follows three phases and can take weeks to a year. Here is why tendons and ligaments heal slowly and what the biology actually allows.

• TB-500 research: what the literature shows

  An honest summary of the TB-500 and Thymosin Beta-4 research landscape: where the evidence is strong, where it is limited, and what the open questions are.

• TB-500 side effects and what the literature reports

  TB-500 side effects in plain English — what the published literature reports, what is rare versus common, and the long-term human safety data gap that should slow anyone down.

• TB-500: what Thymosin Beta-4 is and why it matters

  TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring protein found in nearly every cell of the body. Here is what it is, how it differs from full Thymosin Beta-4, and why it matters.

• The four peptide families: a practical classification for patients

  Peptide families explained in plain English: the four practical groups patients ask about — growth, healing, metabolic, and signaling. Not FDA-approved.

• The four peptide families: a practical classification for patients

  There are dozens of named peptides — but only four practical families to know. Here is a plain-English map so the rest of the field makes sense.

• The growth hormone axis explained: pituitary, GHRH, and IGF-1

  The growth hormone axis explained in plain English: hypothalamus releases GHRH, pituitary releases GH, liver makes IGF-1. The dispatcher–driver–receipt model patients can actually use.

• The hydrophobic effect: why peptides fold the way they do

  The hydrophobic effect is water pushing oily molecules together. It is the main force that folds proteins into their working shapes. Here's how.

• The stack mentality: why more peptides aren't always better

  Adding more peptides to a protocol isn't the same as getting better results. Here's what the research and clinical practice actually say, in plain English.

• What are peptides? A plain-English primer

  Peptides are short chains of amino acids your body already makes. Learn what they are, how they differ from proteins, and why they matter for health research.

• What happens at a peptide telehealth consultation

  A peptide therapy consultation is a real medical visit: intake form, baseline labs, physician review, and a prescription only if it fits. Here is each step.

• What happens to a peptide after you inject it

  After you inject a peptide, it enters the blood, binds its receptors, then enzymes cut it into amino acids. Here's the journey — and why it matters.

• What is a peptide: a plain-English primer

  A peptide is a short chain of amino acids — bigger than a single amino acid, smaller than a protein. Here is what that means, in plain English.

• What is an amino acid? The building block behind every peptide

  Amino acids are the building blocks that link together to form every peptide and protein. Here is what they are and how they make peptides work.

• What is bacteriostatic water, and why peptides are mixed with it

  Bacteriostatic water is the liquid used to mix many peptides. Here is what benzyl alcohol does, how it differs from sterile water, and why it matters.

• What makes a peptide different from a protein?

  Peptides and proteins are built from the same parts, so what's the difference? It mostly comes down to size. Here's the plain-English explanation.

• What to look for in a physician who prescribes peptides

  A practical checklist for evaluating a physician or telehealth service that prescribes peptides — credentials, labs, follow-up, and a few red flags.

• When brain fog means 'see a healthcare provider,' not 'try a peptide'

  Brain fog is a symptom, not a diagnosis. Here are the common medical causes worth ruling out with a physician before assuming a peptide is the answer.

• Where biologics end and peptides begin: the size spectrum

  Peptides and proteins are the same chemistry at different sizes. See where the FDA draws the line, measured in amino acids and daltons, and why it matters.

• Who asks about BPC-157 and what they want to understand

  Who searches for BPC-157, what they want to understand, and why the U.S. regulatory picture comes first. Plain-English answers without the marketing.

• Who asks about TB-500 and the questions they bring

  Who asks about TB-500, what they want to understand, and where U.S. access stands in 2026. Plain-English answers grounded in the published literature.

• Who is searching for information about peptides and why

  Who is researching peptide therapy in 2026 and what they want to know — the search patterns behind the most common questions and the contexts that drive them.

• Who should not use peptides: clinical contraindications

  Some people should not use peptide therapy. Here are the published contraindications physicians screen for — pregnancy, cancer, and unstable illness.

• Why 'boosting' immunity is the wrong mental model

  Can you boost your immune system? A plain-English look at why 'boosting' is the wrong mental model, what balance really means, and what the science supports.

• Why animal studies don't prove human outcomes

  Most peptide research starts in mice, not people. Here is why a result in animals does not promise the same result in humans, in plain English.

• Why drugmakers modify peptides: analogs explained

  A peptide analog is a modified version of a native peptide, tweaked to last longer or bind better. Here's how analogs work, with CJC-1295 as the example.

• Why longevity researchers avoid 'age-reversal' language — and what they use instead

  Words like 'reverse aging' and 'age-reversal' are everywhere in wellness marketing. Longevity researchers almost never use them. Here's why — and what they say instead.

• Why Melatonin Isn't a Sleeping Pill (and What It Actually Does)

  Is melatonin a sleeping pill? Not exactly. Here's the plain-English difference between a timing signal and a sedative, and why that distinction matters.

• Why most peptides can't be pills: the oral delivery problem

  Most peptides cannot be pills because the gut destroys them. Here is why oral peptide delivery is so hard and how researchers are solving it.

• Why peptides are dosed in micrograms, not milligrams

  Peptides work at the receptor level, so doses are measured in micrograms — millionths of a gram. Here's why tiny doses make sense and why precision matters.

• Why peptides come as a freeze-dried powder: lyophilization explained

  Why do peptides arrive as a dry powder instead of a ready liquid? The answer is lyophilization, or freeze-drying. Here is how it works and why it protects them.

• Why peptides come as acetate salts, explained

  Many peptides are made as acetate salts. Here's what a salt form means, why acetate is preferred over trifluoroacetate, and what it means for you.

• Why YouTube peptide dosing differs from physician protocols

  Online peptide doses and clinic protocols often disagree. Here is why that gap exists, in plain English, and which one is built around your safety.